Navigation Links
Researchers demonstrate highly directional terahertz laser rays
Date:8/8/2010

Cambridge, Mass., USA and Leeds, UK August 8, 2010 A collaborative team of applied scientists from Harvard University and the University of Leeds have demonstrated a new terahertz (THz) semiconductor laser that emits beams with a much smaller divergence than conventional THz laser sources. The advance, published in the August 8th issue of Nature Materials, opens the door to a wide range of applications in terahertz science and technology. Harvard has filed a broad patent on the invention.

The finding was spearheaded by postdoctoral fellow Nanfang Yu and Federico Capasso, Robert L. Wallace Professor of Applied Physics and Vinton Hayes Senior Research Fellow in Electrical Engineering, both of Harvard's School of Engineering and Applied Sciences (SEAS), and by a team led by Edmund Linfield at the School of Electronic and Electrical Engineering, University of Leeds.

Terahertz rays (T-rays) can penetrate efficiently through paper, clothing, plastic, and many other materials, making them ideal for detecting concealed weapons and biological agents, imaging tumors without harmful side effects, and spotting defects, such as cracks, within materials. THz radiation is also used for high-sensitivity detection of tiny concentrations of interstellar chemicals.

"Unfortunately, present THz semiconductor lasers are not suitable for many of these applications because their beam is widely divergentsimilar to how light is emitted from a lamp" says Capasso. "By creating an artificial optical structure on the facet of the laser, we were able to generate highly collimated (i.e., tightly bound) rays from the device. This leads to the efficient collection and high concentration of power without the need for conventional, expensive, and bulky lenses."

Specifically, to get around the conventional limitations, the researchers sculpted an array of sub-wavelength-wide grooves, dubbed a metamaterial, directly on the facet of quantum cascade lase
'/>"/>

Contact: Michael Patrick Rutter
mrutter@seas.harvard.edu
617-496-3815
Harvard University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Hebrew University researchers identify gene related to chronic pain
2. UC Riverside researchers measure diesel emissions on the freeway
3. Windy cities: Researchers invent new tool to calculate hurricane risk
4. NSF funds Virginia Tech program to train researchers at intersection of engineering, biology
5. UT Southwestern researchers find key step in bodys ability to make red blood cells
6. Carnegie Mellon researchers create fluorescent biosensor to aid in drug development
7. Ben-Gurion University of the Negev researchers identify risks of hypertension in young adults
8. Researchers discover how key enzyme repairs sun-damaged DNA
9. U of T researchers find link between childhood physical abuse and heart disease
10. Researchers use nanoparticles as destructive beacons to zap tumors
11. Researchers: EPA should recognize environmental impact of protecting foreign oil
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers demonstrate highly directional terahertz laser rays
(Date:7/27/2015)... , July 27, 2015   Zynx Health ... experience-based clinical improvement solutions, today announced that its ... now available on Android smartphones and tablets. With ... post-care organizations can use ZynxCarebook to securely exchange ... condition, streamline care transitions to other care settings, ...
(Date:7/21/2015)... YORK , July 21, 2015 ... systems, as seen in the recent U.S. Office ... a solution to the infosec conundrum, but developers ... is stored. To address this dilemma, Biometrics-as-a-Service provider ... its Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... , July 07, 2015 ... announced the addition of the "Biometrics for ... Forecasts 2015-2020" report to their offering. ... major contributor to this growth and the forecast ... billion in revenue for companies involved in delivering ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... For the first time in nearly a century drinkers will ... heritage barley from the Victorian period. Old varieties ... the John Innes Centre revived Chevallier from the institute,s Genetic ... records indicate that the variety produced premium quality malt and ...
... analysis, carbon dioxide removal could be used under certain ... but it would not replace the bulk of actual ... allows to separate emissions control from the time and ... important for climate protection," says lead-author Elmar Kriegler. "You ...
... "Many of the great whales which once populated the oceans ... commercial hunting. The committee also worried about how tuna fishing ... And they considered reports about seal hunting and the decline ... October of that year, Congress passed the Marine Mammal Protection ...
Cached Biology News:Cheers to better beer and disease resistance 2CO2 removal can lower costs of climate protection 2CO2 removal can lower costs of climate protection 3Sea mammals find US safe harbor 2Sea mammals find US safe harbor 3Sea mammals find US safe harbor 4
(Date:7/30/2015)... , ... July 30, 2015 , ... ... of a field clinical study of its canine osteoarthritis stem cell product, currently ... Therapeutics (Kansas City, KS) and will be marketed in the US by Aratana. ...
(Date:7/30/2015)... Senomyx , Inc. (NASDAQ: SNMX ), a leading ... and commercialize novel flavor ingredients for the food, beverage, ... the second quarter 2015. "Moving into ... to achieve our commercial and financial goals," stated John ... "Since our last quarterly earnings report, our two partners ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/30/2015)... July 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... received the second $1.0M tranche under a previously ... grant valued at up to $3.0 million to ... surfactant as a potential medical countermeasure to mitigate ... was awarded an initial $1.0 million under this ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... Calif., Aug. 19 ReceptorBio,Inc. announced today that ... Inc. (Palo Alto, CA) (Nasdaq: TELK ) ... unique, oral small molecule insulin,receptor activators. These compounds ... drug discovery technology. The,agreement provides for payments related ...
... software,solutions provider for cheminformatics today announced the launch ... JChem. As well as,other improvements, the release sees ... 2 format useful for integrating with Microsoft Office,applications., ... of application programming,interfaces (API,s) and graphic user interfaces ...
... 19 Today Bavarian,Nordic published the company,s interim report ... available on the company,s website. Below is an,extract of ... as events,after the balance sheet date., In the ... DKK 23,million and recorded a loss before tax of ...
Cached Biology Technology:ReceptorBio Announces Diabetes License Agreement With Telik 2ReceptorBio Announces Diabetes License Agreement With Telik 3ChemAxon Launches Marvin and JChem Version 5.1; Name to Structure Generation, OLE 2 and JavaScript Integration 2Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 2Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 3Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 4Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 5Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 6Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 7Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 8Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 9Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 10
Rabbit polyclonal to KIAA1276 ( Abpromise for all tested applications). entrezGeneID: 27146 SwissProtID: Q9ULE4...
Mouse monoclonal [LH8] to Cytokeratin 5 + 14 ( Abpromise for all tested applications). entrezGeneID: 3852 SwissProtID: P02533...
Rabbit polyclonal to IL23 P19 ( Abpromise for all tested applications). Antigen: Synthetic 16 amino acid peptide from near the amino terminus of human IL23 P19 Entrez Gene ID: 51561 Swiss...
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: